Nuwellis, Inc. (NUWE)
- Previous Close
0.2482 - Open
0.2381 - Bid 0.2294 x 1400
- Ask 0.2350 x 3000
- Day's Range
0.2257 - 0.2484 - 52 Week Range
0.1300 - 3.8300 - Volume
2,208,449 - Avg. Volume
5,628,606 - Market Cap (intraday)
3.551M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-6.3600 - Earnings Date Aug 6, 2024 - Aug 12, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
9.00
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
www.nuwellis.comRecent News: NUWE
Performance Overview: NUWE
Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NUWE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NUWE
Valuation Measures
Market Cap
3.78M
Enterprise Value
3.09M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.09
Price/Book (mrq)
4.27
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-202.97%
Return on Assets (ttm)
-82.18%
Return on Equity (ttm)
-248.15%
Revenue (ttm)
8.89M
Net Income Avi to Common (ttm)
-21.01M
Diluted EPS (ttm)
-6.3600
Balance Sheet and Cash Flow
Total Cash (mrq)
1.4M
Total Debt/Equity (mrq)
79.93%
Levered Free Cash Flow (ttm)
-10.72M
Research Analysis: NUWE
Company Insights: NUWE
NUWE does not have Company Insights